This would seem to suggest that rapamycin (with an optimized dosing protocol) could in fact help prevent sarcopenia (as shown in mouse models).
Sarcopenia—the age-related loss of skeletal muscle mass and strength—remains a major barrier to human longevity. While transient activation of the mechanistic target of rapamycin complex 1 (mTORC1) pathway is fundamental for muscle growth, chronic overactivation of this pathway is tightly linked to age-related muscle wasting and mitochondrial decay. Because natural aging involves a gradual, systemic rise in mTORC1 activity, separating its direct downstream consequences from chronological decay has historically proven difficult.
To bypass this hurdle, researchers isolated the standalone effects of chronic muscle-specific mTORC1 hyperactivation using an inducible DEP domain-containing protein 5 muscle-specific knockout (DEPDC5 mKO) mouse model. They sought to determine whether a standard therapeutic intervention— 8 weeks of progressive endurance treadmill training — could override this genetic hyperactivation or successfully rescue muscle quality and physical performance.
The results reveal a stark physiological paradox. Following the exercise protocol, the hyperactive mTORC1 mice exhibited structural hypertrophic gains, notably an increase in tibialis anterior muscle mass, alongside a substantial increase in absolute mitochondrial respiration and citrate synthase activity. However, these structural and biochemical improvements completely failed to translate into functional fitness. The trained knockout mice demonstrated zero improvements in maximal running speed to exhaustion, grip strength, in vivo muscle torque, or ex vivo specific force production.
Omics profiling exposed a profound state of metabolic inflexibility driven by the hyperactive pathway. While wild-type mice adapted to endurance training by downregulating glycolytic intermediates and upregulating broad mitochondrial gene networks, the hyperactive mTORC1 cohorts experienced zero adaptive shifts in their metabolome. Instead, under the stress of exercise, they selectively depleted long-chain triglycerides and vital cell membrane phosphatidylcholines. This strongly indicates that chronic mTORC1 forcing induces mitochondrial uncoupling or severe operational inefficiency; the muscle builds more mitochondria but burns through its own structural lipid architecture to sustain them, rendering the physical training functionally futile.
Actionable Insights
-
mTORC1 Dampening Prior to Exercise Forcing: Pushing intense endurance or physical training protocols while baseline mTORC1 is chronically elevated—such as in advanced age or metabolic disease—is functionally inefficient. Longevity protocols should prioritize downregulating baseline mTORC1 via targeted pharmacology (e.g., rapamycin), caloric restriction mimetics, or structured fasting windows to reset baseline cell signaling and restore autophagic flux before expecting structural muscle adaptations to yield actual physical performance and functional healthspan gains.
-
Mitigating Metabolic Inflexibility: Chronic mTORC1 overactivation limits the muscle’s capacity to flexibly switch between energy substrates during exercise stress. Because hyperactive mTORC1 forcing pathologically accelerates the depletion of critical structural lipids like phosphatidylcholines (PCs) to manage mitochondrial stress, individuals with suspected age-related mTORC1 elevation must strictly monitor and support cell membrane integrity. Supplementation with high-purity phosphatidylcholine or targeted lipid therapies may protect against the oxidative membrane damage and secondary lipid source depletion observed under high metabolic strain.
Source:
- Open Access Paper: Hyperactive muscle mTORC1 attenuates functional adaptations to endurance training despite alterations in mitochondrial and lipid profiles
- Institutions: Department of Cellular and Integrative Physiology, Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, Texas; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA.
- Journal Name: Journal of Applied Physiology.
- Impact Evaluation The impact score of this journal is 3.3, evaluated against a typical high-end range of 0–60+ for top general science, therefore this is a Medium impact journal.